You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Hypertension

Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]

  • In development
  • Reference number: GID-TA11572
  • Expected publication date:  21 May 2026
  • Project information
  • Project documents

On this page

  1. Draft guidance
  2. Invitation to participate
  3. Notes
  4. Referral
  5. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6459
  6. Topic selection

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Draft guidance (online commenting)

  • Draft guidance (downloadable version) (PDF 324 KB)

    Published:
    23 January 2026
  • Committee papers (PDF 13.2 MB)

    Published:
    23 January 2026
  • Public committee slides (PDF 1.12 MB)

    Published:
    23 January 2026
  • Equality impact assessment (downloadable version) (PDF 156 KB)

    Published:
    23 January 2026

Invitation to participate

  • Final scope (PDF 118 KB)

    Published:
    10 March 2025
  • Provisional stakeholder list (post-referral) (PDF 134 KB)

    Published:
    10 March 2025
  • Draft scope and provisional stakeholder list comments table (post-referral) (PDF 292 KB)

    Published:
    10 March 2025
  • Equality impact assessment (downloadable version) (PDF 107 KB)

    Published:
    10 March 2025

Notes

  • Note

  • Note

Referral

  • Referral

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6459

  • Draft matrix post referral (PDF 197 KB)

    Published:
    04 November 2024
  • Draft scope post referral (PDF 191 KB)

    Published:
    04 November 2024

Topic selection

  • Topic selection

Back to top